Federica Invernizzi

Federica Invernizzi

Auto-generated profile, based on publicly available information

Federica Invernizzi

Division of Gastroenterology and Hepatology, University of Milan, Milan, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in United European Gastroenterology Journal
Verified
Journal Article
Open access
PDF file
Marco SpadacciniMarco Spadaccini
Marco Spadaccini
AAAlessio Aghemo
Alessio Aghemo
FCFlavio Andrea Caprioli
Flavio Andrea Caprioli
Ana LleoAna Lleo
Ana Lleo
FIFederica Invernizzi
Federica Invernizzi
MDMARIA FRANCESCA DONATO
MARIA FRANCESCA DONATO
Background: The management of inflammatory bowel disease in patients who have previously undergone liver transplantation can be a clinical challenge. There are serious concerns among physicians regarding the use of biologics for treating such immuno‐compromised patients.Objective: We performed a systematic review on vedolizumab therapy in transplant recipients to assess its safety.Methods: PubMed/Embase/Scopus were searched up to November 2018 to identify papers regarding liver transplant recipients and therapy with vedolizumab. Primary outcomes were adverse events. Secondary outcomes were liver transplant and inflammatory bowel disease outcomes.Results: Eight studies (31 patients) were included. Nine out of 31 patients experienced an infection within a mean follow‐up time ranging from 5–20 months. No malignancies were reported. Inflammatory bowel disease clinical response was experienced by 20/26 patients. Abnormalities in liver tests were recorded in 2/22 patients.Conclusion: Vedolizumab may be considered safe for treating inflammatory bowel disease in liver transplant recipients. Caution is recommended for patients with an unstable liver graft function.

1 April 2013 in Journal of Hepatology
Verified
Journal Article
Open access
PLPietro Lampertico
Pietro Lampertico
RSR. Soffredini
R. Soffredini
Mauro ViganòMauro Viganò
Mauro Viganò
EME. Minola
E. Minola
GCG. Cologni
G. Cologni
MCM. Colombo
M. Colombo

1 March 2021 in Digestive and Liver Disease
Verified
Journal Article
Closed access
SSS.S. Sciarrone
S.S. Sciarrone
Alberto FerrareseAlberto Ferrarese
Alberto Ferrarese
SVS. Volpato
S. Volpato
MDMARIA FRANCESCA DONATO
MARIA FRANCESCA DONATO
FIF. Invernizzi
F. Invernizzi
PBPatrizia Burra
Patrizia Burra

1 March 2021 in Digestive and Liver Disease
Verified
Journal Article
Open access
Giovanni PerriconeGiovanni Perricone
Giovanni Perricone
RVR. Vigano
R. Vigano
CMChiara Mazzarelli
Chiara Mazzarelli
GTGiovanna Travi
Giovanna Travi
LPL. Pasulo
L. Pasulo
EBe L.S. Belli
e L.S. Belli